In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies.
about
Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them.Advancing Regulatory Science With Computational Modeling for Medical Devices at the FDA's Office of Science and Engineering Laboratories
P2860
In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
In silico assessment of biomed ...... re events in two case studies.
@ast
In silico assessment of biomed ...... re events in two case studies.
@en
type
label
In silico assessment of biomed ...... re events in two case studies.
@ast
In silico assessment of biomed ...... re events in two case studies.
@en
prefLabel
In silico assessment of biomed ...... re events in two case studies.
@ast
In silico assessment of biomed ...... re events in two case studies.
@en
P2093
P2860
P356
P1433
P1476
In silico assessment of biomed ...... re events in two case studies.
@en
P2093
Adam Himes
Boris Kovatchev
Marco Viceconti
Mark Palmer
Tarek Haddad
P2860
P304
P356
10.1177/0954411917702931
P577
2017-05-01T00:00:00Z